首页 > 最新文献

Revista clinica espanola最新文献

英文 中文
The value of multi-modal ultrasound in the assessment of sarcopenia in maintenance hemodialysis patients 多模态超声在评估维持性血液透析患者肌少症中的价值。
Pub Date : 2024-08-01 DOI: 10.1016/j.rceng.2024.06.003

Introduction

Sarcopenia is one of the common complications in maintenance hemodialysis (MHD) patients and is associated with poor prognosis. We aimed to study the validity and reliability of ultrasound in the assessment of sarcopenia in MHD patients.

Methods

MHD patients were categorized into the sarcopenia group and the non-sarcopenia group according to the diagnostic criteria of the Asian Working Group on Sarcopenia (AWGS) 2019. Ultrasonography of the left medial head of the gastrocnemius muscle was performed in MHD and healthy controls to obtain muscle thickness (MT), pinnation angle (PA), fascicle length (FL), cross-sectional area (CSA), echo intensity (EI), elastic modulus (E), shear wave velocity (SWV), and microvascular velocity (MV). Compare the differences in ultrasound parameters among different groups, and determine the cut-off values suitable for diagnosing sarcopenia in MHD patients.

Results

The MT, CSA, PA, and MV in the sarcopenia group were lower than those in the non-sarcopenia group and the control group; while the EI was higher, the FL of the sarcopenia group was lower than that of the non-sarcopenia group, while the E and SWV of the sarcopenia group were higher than those of the control group. Receiver operating characteristic curve analyses indicated that ultrasound combined index had a good diagnostic value, model Y = 13.511−0.121*MT-0.609*CSA-0.172*PA+0.011*EI-2.205*MV(P < 0.05), with a cut-off value of 0.69.

Conclusions

Multi-modal ultrasound is a safe, non-invasive, and real-time imaging examination method, and can provide information on muscle structure, stiffness, and perfusion, which is expected to be a promising potential tool for predicting sarcopenia in MHD patients.

简介:肌肉疏松症是维持性血液透析(MHD)患者常见的并发症之一,与预后不良有关。我们旨在研究超声波评估肌肉疏松症的有效性和可靠性:根据亚洲肌肉疏松症工作组(AWGS)2019 年的诊断标准,将 MHD 患者分为肌肉疏松症组和非肌肉疏松症组。对MHD患者和健康对照组的腓肠肌左内侧头进行超声检查,以获得肌肉厚度(MT)、羽状角(PA)、筋膜长度(FL)、横截面积(CSA)、回声强度(EI)、弹性模量(E)、剪切波速度(SWV)和微血管速度(MV)。比较不同组间超声参数的差异,并确定适合诊断 MHD 患者肌少症的临界值:肌肉疏松症组的 MT、CSA、PA 和 MV 均低于非肌肉疏松症组和对照组;肌肉疏松症组的 EI 较高,FL 则低于非肌肉疏松症组,而 E 和 SWV 则高于对照组。接收者操作特征曲线分析表明,超声综合指数具有良好的诊断价值,模型Y=13.511-0.121*MT-0.609*CSA-0.172*PA+0.011*EI-2.205*MV(P 结论:超声综合指数具有良好的诊断价值:多模态超声是一种安全、无创、实时的成像检查方法,可提供肌肉结构、僵硬度和灌注信息,有望成为预测 MHD 患者肌少症的潜在工具。
{"title":"The value of multi-modal ultrasound in the assessment of sarcopenia in maintenance hemodialysis patients","authors":"","doi":"10.1016/j.rceng.2024.06.003","DOIUrl":"10.1016/j.rceng.2024.06.003","url":null,"abstract":"<div><h3>Introduction</h3><p>Sarcopenia is one of the common complications in maintenance hemodialysis (MHD) patients and is associated with poor prognosis. We aimed to study the validity and reliability of ultrasound in the assessment of sarcopenia in MHD patients.</p></div><div><h3>Methods</h3><p>MHD patients were categorized into the sarcopenia group and the non-sarcopenia group according to the diagnostic criteria of the Asian Working Group on Sarcopenia (AWGS) 2019. Ultrasonography of the left medial head of the gastrocnemius muscle was performed in MHD and healthy controls to obtain muscle thickness (MT), pinnation angle (PA), fascicle length (FL), cross-sectional area (CSA), echo intensity (EI), elastic modulus (E), shear wave velocity (SWV), and microvascular velocity (MV). Compare the differences in ultrasound parameters among different groups, and determine the cut-off values suitable for diagnosing sarcopenia in MHD patients.</p></div><div><h3>Results</h3><p>The MT, CSA, PA, and MV in the sarcopenia group were lower than those in the non-sarcopenia group and the control group; while the EI was higher, the FL of the sarcopenia group was lower than that of the non-sarcopenia group, while the E and SWV of the sarcopenia group were higher than those of the control group. Receiver operating characteristic curve analyses indicated that ultrasound combined index had a good diagnostic value, model <em>Y</em> = 13.511−0.121*MT-0.609*CSA-0.172*PA+0.011*EI-2.205*MV(<em>P</em> &lt; 0.05), with a cut-off value of 0.69.</p></div><div><h3>Conclusions</h3><p>Multi-modal ultrasound is a safe, non-invasive, and real-time imaging examination method, and can provide information on muscle structure, stiffness, and perfusion, which is expected to be a promising potential tool for predicting sarcopenia in MHD patients.</p></div>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":"224 7","pages":"Pages 437-444"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2254887424000821/pdfft?md5=a0c3c97314799d9991c3f3ee011e5206&pid=1-s2.0-S2254887424000821-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141289098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The young internist at the leading edge of clinical research 处于临床研究前沿的年轻内科医生。
Pub Date : 2024-08-01 DOI: 10.1016/j.rceng.2024.06.004
{"title":"The young internist at the leading edge of clinical research","authors":"","doi":"10.1016/j.rceng.2024.06.004","DOIUrl":"10.1016/j.rceng.2024.06.004","url":null,"abstract":"","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":"224 7","pages":"Pages 479-480"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141294040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and characteristics of anemia in patients with diabetes mellitus aged 50 or older in health unit area of Cadiz (Spain) 加的斯(西班牙)卫生单位地区 50 岁及以上糖尿病患者的贫血患病率和特征。
Pub Date : 2024-08-01 DOI: 10.1016/j.rceng.2024.06.008

Background

Anemia is a common comorbidity in patients with diabetes mellitus (DM), particularly in older adults. However, there is a lack of data on the prevalence and the characteristics of anemia in this population in Spain.

Objective

To describe the prevalence and the characteristics of anemia in patients with DM aged 50 or older (PDM50) in a healthcare district in the province of Cádiz.

Methods

A retrospective cross-sectional study was conducted that included outpatient’s laboratory tests (OLT) performed over 30 months at PDM50.

Results

The prevalence of anemia was 29.9% (95% CI: 28.7%–31.1%), predominating in women (33.3% vs 26.7%; P < 0.01), in older people stratified by decades (61.7% in 9th decade vs 12% in 5th decade; P < 0.01), and in those with kidney disease (44.7% vs 28%; P < 0.01). Most cases were mild (68.3%), normocytic (78.7%), and hypochromic (52%). Similarly, moderate-to-severe anemia was more frequent in women (39% vs 23%), their prevalence increased with age (45% in the 9th decade vs 24% in the 5th decade), and with the progression of kidney damage, either measured by a decreased glomerular filtration rate (GFR) (49% in G4 vs 25% in G1), or the presence of albuminuria (P < 0.01). No association was found between DM control, based on glycated hemoglobin (HbA1c), and anemia in either sex (P = 0.887).

Conclusion

This study describes a high prevalence of anemia in PDM50, particularly in women, in the most advantageous people and in the presence of kidney disease, even in early stages, highlighting the clinical importance of this coexistence.

背景:贫血是糖尿病(DM)患者,尤其是老年人的常见合并症。然而,目前还缺乏有关西班牙此类人群贫血患病率和特征的数据:描述加的斯省一个医疗区 50 岁或以上 DM 患者(PDM50)的贫血患病率和特征:方法:进行了一项回顾性横断面研究,包括在 PDM50 患者中 30 个月内进行的门诊化验检查(OLT):结果:贫血患病率为 29.9%(95% CI:28.7-31.1%),以女性为主(33.3% vs 26.7%;P 结论:该研究描述了贫血的高患病率:本研究描述了 PDM50 中贫血的高发率,尤其是在女性、最弱势人群和存在肾脏疾病的人群中,即使是在早期阶段也是如此,突出了这种并存现象的临床重要性。
{"title":"Prevalence and characteristics of anemia in patients with diabetes mellitus aged 50 or older in health unit area of Cadiz (Spain)","authors":"","doi":"10.1016/j.rceng.2024.06.008","DOIUrl":"10.1016/j.rceng.2024.06.008","url":null,"abstract":"<div><h3>Background</h3><p>Anemia is a common comorbidity in patients with diabetes mellitus (DM), particularly in older adults. However, there is a lack of data on the prevalence and the characteristics of anemia in this population in Spain.</p></div><div><h3>Objective</h3><p>To describe the prevalence and the characteristics of anemia in patients with DM aged 50 or older (PDM50) in a healthcare district in the province of Cádiz.</p></div><div><h3>Methods</h3><p>A retrospective cross-sectional study was conducted that included outpatient’s laboratory tests (OLT) performed over 30 months at PDM50.</p></div><div><h3>Results</h3><p>The prevalence of anemia was 29.9% (95% CI: 28.7%–31.1%), predominating in women (33.3% vs 26.7%; <em>P</em> &lt; 0.01), in older people stratified by decades (61.7% in 9th decade vs 12% in 5th decade; <em>P</em><span> &lt; 0.01), and in those with kidney disease (44.7% vs 28%; </span><em>P</em><span><span><span> &lt; 0.01). Most cases were mild (68.3%), normocytic (78.7%), and hypochromic (52%). Similarly, moderate-to-severe anemia was more frequent in women (39% vs 23%), their prevalence increased with age (45% in the 9th decade vs 24% in the 5th decade), and with the progression of kidney damage, either measured by a decreased </span>glomerular filtration rate (GFR) (49% in G4 vs 25% in G1), or the presence of </span>albuminuria (</span><em>P</em><span> &lt; 0.01). No association was found between DM control, based on glycated hemoglobin (HbA1c), and anemia in either sex (</span><em>P</em> = 0.887).</p></div><div><h3>Conclusion</h3><p>This study describes a high prevalence of anemia in PDM50, particularly in women, in the most advantageous people and in the presence of kidney disease, even in early stages, highlighting the clinical importance of this coexistence.</p></div>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":"224 7","pages":"Pages 457-465"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141328264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Etiological spectrum and diagnostic challenges of short-duration fever in West Bengal (India). A cross-sectional tertiary care study 印度西孟加拉邦短程发热的病因谱和诊断难题:一项横断面三级护理研究。
Pub Date : 2024-08-01 DOI: 10.1016/j.rceng.2024.06.009

Introduction

The scarcity of epidemiological data on acute febrile illnesses from South Asia impairs evidence-based clinical decision-making. Our study aimed to explore the etiological spectrum of short-duration fever in patients admitted to a tertiary care hospital in West Bengal, India.

Methods

We conducted a cross-sectional study from May 2021 to April 2022 involving 150 adult patients presenting with a fever lasting less than two weeks at Burdwan Medical College and Hospital (West Bengal, India). We performed comprehensive clinical assessments, including microbiological, serological, and other specific investigations, to identify the causes of the fever.

Results

The demographic profile predominantly included individuals aged 21–40 years, with a male-to-female ratio of 1.9:1; 60.7% of participants were from rural areas. The primary etiological agents identified were scrub typhus (25.3%), dengue (15.3%), and enteric fever (13.3%). Notably, 80% of patients presented with non-localizing symptoms, while 14.7% had respiratory symptoms. Blood cultures pinpointed Salmonella typhi and Staphylococcus aureus in a minority of cases (3.3%); malaria, primarily Plasmodium vivax, was diagnosed in 12% of the cases.

Conclusion

Our findings highlight the complexity of diagnosing short-duration fevers, dominated by a wide range of etiological agents, with a notable prevalence of scrub typhus. These results underscore the urgent need for enhanced diagnostic facilities, including the availability of scrub typhus testing at primary healthcare centers. We recommend empirical doxycycline therapy for suspected cases and emphasize the need for further research to develop management guidelines for acute febrile illnesses. This study also highlights the importance of raising both community and clinician awareness to prevent irrational antibiotic use.

导言:南亚地区急性发热疾病的流行病学数据稀缺,这影响了以证据为基础的临床决策。我们的研究旨在探索印度西孟加拉邦一家三级医院收治的短期发热患者的病因谱:我们于 2021 年 5 月至 2022 年 4 月在 Burdwan 医学院和医院(印度西孟加拉邦)开展了一项横断面研究,涉及 150 名发热持续时间不到两周的成年患者。我们进行了全面的临床评估,包括微生物学、血清学和其他特定检查,以确定发烧的原因:人口统计学特征主要包括 21-40 岁的人,男女比例为 1.9:1,60.7% 的参与者来自农村地区。主要病原体为恙虫病(25.3%)、登革热(15.3%)和肠热(13.3%)。值得注意的是,80%的患者表现为非局部症状,14.7%的患者有呼吸道症状。少数病例(3.3%)的血液培养结果为伤寒沙门氏菌和金黄色葡萄球菌,12%的病例被诊断为疟疾,主要是间日疟原虫:我们的研究结果凸显了短时发热诊断的复杂性,病原体种类繁多,其中恙虫病的发病率较高。这些结果突出表明,迫切需要加强诊断设施,包括在初级医疗保健中心提供恙虫病检测。我们建议对疑似病例进行经验性强力霉素治疗,并强调有必要开展进一步研究,以制定完善的急性发热性疾病管理指南。这项研究还强调了提高社区和临床医生对防止不合理使用抗生素的认识的重要性。
{"title":"Etiological spectrum and diagnostic challenges of short-duration fever in West Bengal (India). A cross-sectional tertiary care study","authors":"","doi":"10.1016/j.rceng.2024.06.009","DOIUrl":"10.1016/j.rceng.2024.06.009","url":null,"abstract":"<div><h3>Introduction</h3><p>The scarcity of epidemiological data on acute febrile illnesses from South Asia impairs evidence-based clinical decision-making. Our study aimed to explore the etiological spectrum of short-duration fever in patients admitted to a tertiary care hospital in West Bengal, India.</p></div><div><h3>Methods</h3><p>We conducted a cross-sectional study from May 2021 to April 2022 involving 150 adult patients presenting with a fever lasting less than two weeks at Burdwan Medical College and Hospital (West Bengal, India). We performed comprehensive clinical assessments, including microbiological, serological, and other specific investigations, to identify the causes of the fever.</p></div><div><h3>Results</h3><p><span><span>The demographic profile predominantly included individuals aged 21–40 years, with a male-to-female ratio of 1.9:1; 60.7% of participants were from rural areas. The primary etiological agents identified were scrub typhus<span> (25.3%), dengue (15.3%), and </span></span>enteric fever (13.3%). Notably, 80% of patients presented with non-localizing symptoms, while 14.7% had respiratory symptoms. Blood cultures pinpointed </span><span><span>Salmonella typhi</span></span> and <span><span>Staphylococcus aureus</span></span> in a minority of cases (3.3%); malaria, primarily <span><span>Plasmodium vivax</span></span>, was diagnosed in 12% of the cases.</p></div><div><h3>Conclusion</h3><p><span>Our findings highlight the complexity of diagnosing short-duration fevers, dominated by a wide range of etiological agents, with a notable prevalence of scrub typhus<span>. These results underscore the urgent need for enhanced diagnostic facilities, including the availability of scrub typhus testing at primary healthcare centers. We recommend empirical </span></span>doxycycline<span> therapy for suspected cases and emphasize the need for further research to develop management guidelines for acute febrile illnesses. This study also highlights the importance of raising both community and clinician awareness to prevent irrational antibiotic use.</span></p></div>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":"224 7","pages":"Pages 466-473"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141437958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic accuracy of procalcitonin for bacterial infection in the Emergency Department: a systematic review 急诊科细菌感染的降钙素原诊断准确性:系统综述。
Pub Date : 2024-06-01 DOI: 10.1016/j.rceng.2024.05.006
A. Julián-Jiménez , L. García de Guadiana-Romualdo , G. Merinos-Sánchez , D.E. García

Introduction and objective

The care of patients with a suspected infectious process in hospital emergency departments (ED) accounts for 15%–35% of all daily care in these healthcare areas in Spain and Latin America. The early and adequate administration of antibiotic treatment (AB) and the immediate making of other diagnostic-therapeutic decisions have a direct impact on the survival of patients with severe bacterial infection. The main objective of this systematic review is to investigate the diagnostic accuracy of PCT to predict bacterial infection in adult patients treated with clinical suspicion of infection in the ED, as well as to analyze whether the different studies manage to identify a specific value of PCT as the most relevant from the diagnostic point of view of clinical decision that can be recommended for decision making in ED.

Method

A systematic review is carried out following the PRISMA regulations in the database of PubMed, Web of Science, EMBASE, Lilacs, Cochrane, Epistemonikos, Tripdatabase and ClinicalTrials.gov from January 2005 to May 31, 2023 without language restriction and using a combination of MESH terms: “Procalcitonin”, “Infection/Bacterial Infection/Sepsis”, “Emergencies/Emergency/Emergency Department”, “Adults” and “Diagnostic”. Observational cohort studies (diagnostic performance analyses) were included. The Newcastle-Ottawa Scale (NOS) was used to assess the quality of the method used and the risk of bias of the included articles. Observational cohort studies were included. No meta-analysis techniques were performed, but results were compared narratively.

Results

A total of 1,323 articles were identified, of which 21 that met the inclusion criteria were finally analyzed. The studies include 10,333 patients with 4,856 bacterial infections (47%). Eight studies were rated as high, 9 as moderate, and 4 as low. The AUC-ROC of all studies ranges from 0.68 (95% CI: 0.61–0.72) to 0.99 (95% CI: 0.98–1). The value of PCT 0.2–0.3 ng/ml is the most used and proposed in up to twelve of the works included in this review whose average estimated performance is an AUC-ROC of 0.79. If only the results of the 5 high-quality studies using a cut-off point of 0.2–0.3 ng/ml PCT are taken into account, the estimated mean AUC-COR result is 0.78 with Se:69 % and Es:76%.

Conclusions

PCT has considerable diagnostic accuracy for bacterial infection in patients treated in ED for different infectious processes. The cut-off point of 0.25 (0.2–0.3) ng/ml has been positioned as the most appropriate to predict the existence of bacterial infection and can be used to help reasonably rule it out.

引言和目的:在西班牙和拉丁美洲,医院急诊科(ED)对疑似感染性疾病患者的治疗占这些医疗机构日常治疗总量的 15%-35%。及早、充分地使用抗生素治疗(AB)并立即做出其他诊断治疗决定对严重细菌感染患者的存活率有直接影响。本系统性综述的主要目的是研究 PCT 预测急诊室临床怀疑感染的成人患者细菌感染的诊断准确性,并分析不同的研究是否能从临床决策的诊断角度确定 PCT 的特定值,以推荐用于急诊室的决策:方法:按照 PRISMA 规定,从 2005 年 1 月至 2023 年 5 月 31 日,在 PubMed、Web of Science、EMBASE、Lilacs、Cochrane、Epistemonikos、Tripdatabase 和 ClinicalTrials.gov 数据库中进行了系统性综述,没有语言限制,并结合使用了 MESH 术语:"降钙素原"、"感染/细菌感染/败血症"、"急症/急诊/急诊科"、"成人 "和 "诊断"。包括观察性队列研究(诊断性能分析)。采用纽卡斯尔-渥太华量表(NOS)评估所采用方法的质量和纳入文章的偏倚风险。纳入了观察性队列研究。未进行荟萃分析,但对结果进行了叙述性比较:共发现 1,323 篇文章,最终分析了其中 21 篇符合纳入标准的文章。这些研究包括 10333 名患者,其中有 4856 例细菌感染(占 47%)。其中 8 项研究被评为高度研究,9 项研究被评为中度研究,4 项研究被评为低度研究。所有研究的 AUC-ROC 从 0.68(95% CI:0.61-0.72)到 0.99(95% CI:0.98-1)不等。PCT 值 0.2-0.3 纳克/毫升是使用最多的值,在本综述所包含的多达 12 项研究中都提出了这一值,其平均估计值为 AUC-ROC 0.79。如果只考虑 5 项采用 0.2-0.3 纳克/毫升 PCT 临界点的高质量研究结果,估计平均 AUC-COR 结果为 0.78,Se:69%,Es:76%:PCT对因不同感染过程而在急诊室接受治疗的患者的细菌感染具有相当高的诊断准确性。0.25(0.2-0.3)纳克/毫升的临界点被定位为预测细菌感染的最合适点,可用于帮助合理排除细菌感染。
{"title":"Diagnostic accuracy of procalcitonin for bacterial infection in the Emergency Department: a systematic review","authors":"A. Julián-Jiménez ,&nbsp;L. García de Guadiana-Romualdo ,&nbsp;G. Merinos-Sánchez ,&nbsp;D.E. García","doi":"10.1016/j.rceng.2024.05.006","DOIUrl":"10.1016/j.rceng.2024.05.006","url":null,"abstract":"<div><h3>Introduction and objective</h3><p>The care of patients with a suspected infectious process in hospital emergency departments (ED) accounts for 15%–35% of all daily care in these healthcare areas in Spain and Latin America. The early and adequate administration of antibiotic treatment (AB) and the immediate making of other diagnostic-therapeutic decisions have a direct impact on the survival of patients with severe bacterial infection. The main objective of this systematic review is to investigate the diagnostic accuracy of PCT to predict bacterial infection in adult patients treated with clinical suspicion of infection in the ED, as well as to analyze whether the different studies manage to identify a specific value of PCT as the most relevant from the diagnostic point of view of clinical decision that can be recommended for decision making in ED.</p></div><div><h3>Method</h3><p>A systematic review is carried out following the PRISMA regulations in the database of PubMed, Web of Science, EMBASE, Lilacs, Cochrane, Epistemonikos, Tripdatabase and ClinicalTrials.gov from January 2005 to May 31, 2023 without language restriction and using a combination of MESH terms: “Procalcitonin”, “Infection/Bacterial Infection/Sepsis”, “Emergencies/Emergency/Emergency Department”, “Adults” and “Diagnostic”. Observational cohort studies (diagnostic performance analyses) were included. The Newcastle-Ottawa Scale (NOS) was used to assess the quality of the method used and the risk of bias of the included articles. Observational cohort studies were included. No meta-analysis techniques were performed, but results were compared narratively.</p></div><div><h3>Results</h3><p>A total of 1,323 articles were identified, of which 21 that met the inclusion criteria were finally analyzed. The studies include 10,333 patients with 4,856 bacterial infections (47%). Eight studies were rated as high, 9 as moderate, and 4 as low. The AUC-ROC of all studies ranges from 0.68 (95% CI: 0.61–0.72) to 0.99 (95% CI: 0.98–1). The value of PCT 0.2–0.3 ng/ml is the most used and proposed in up to twelve of the works included in this review whose average estimated performance is an AUC-ROC of 0.79. If only the results of the 5 high-quality studies using a cut-off point of 0.2–0.3 ng/ml PCT are taken into account, the estimated mean AUC-COR result is 0.78 with Se:69 % and Es:76%.</p></div><div><h3>Conclusions</h3><p>PCT has considerable diagnostic accuracy for bacterial infection in patients treated in ED for different infectious processes. The cut-off point of 0.25 (0.2–0.3) ng/ml has been positioned as the most appropriate to predict the existence of bacterial infection and can be used to help reasonably rule it out.</p></div>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":"224 6","pages":"Pages 400-416"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141180977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing pregnancy outcomes in patients with Systemic Lupus Erythematosus (SLE) and Undifferentiated Connective Tissue Disease (UCTD): a descriptive cohort study 比较系统性红斑狼疮(SLE)和未分化结缔组织病(UCTD)患者的妊娠结局:一项描述性队列研究
Pub Date : 2024-06-01 DOI: 10.1016/j.rceng.2024.04.013
Candido Muñoz Muñoz , Filipa Farinha , Thomas McDonnell , Hajar J'bari , Hanh Nguyen , David Isenberg , Anisur Rahman , David Williams , Jaume Alijotas-Reig , Ian Giles

Background

Females diagnosed with systemic lupus erythematosus (SLE) face an elevated risk of adverse pregnancy outcomes (APOs). However, the evidence regarding whether a similar association exists in patients with undifferentiated connective tissue disease (UCTD) is inconclusive.

Methods

We conducted a retrospective review (2006–2019) of pregnancy outcomes among patients with SLE (n = 51) and UCTD (n = 20) within our institution. We examined the occurrence of various APOs, encompassing miscarriage, stillbirth, termination, preterm birth, pre-eclampsia, eclampsia, HELLP syndrome, intrauterine growth restriction, abruption placentae, congenital heart block, or other cardiac abnormalities.

Results

The mean age at pregnancy was 35 ± 7.0 years for patients with SLE and 35 ± 6.8 years for those with UCTD (p = 0.349). The proportion of Caucasian women was 47% in SLE and 80% in UCTD. Pregnancies in both groups were planned (81% in SLE and 77% in UCTD), and patients presented with inactive disease at conception (96% in SLE and 89% in UCTD). Hydroxychloroquine at conception was utilized by 86% of women with SLE, in contrast to 36% in the UCTD group. Both, SLE and UCTD cohorts exhibited low rates of disease flares during pregnancy and/or puerperium (14% vs. 10%). The incidence of APOs was 15.6% in SLE patients compared to 5% in those with UCTD (Risk difference 19.5%; 95% confidence interval: −3.9 to 43.1; p = 0.4237).

Conclusion

Our study underscores the importance of strategic pregnancy planning and the maintenance of appropriate treatment throughout pregnancy to ensure optimal disease management and minimize adverse outcomes in both SLE and UCTD pregnancies.

背景被诊断患有系统性红斑狼疮(SLE)的女性面临不良妊娠结局(APO)的风险升高。方法我们对本机构的系统性红斑狼疮患者(51 人)和未分化结缔组织病患者(20 人)的妊娠结局进行了回顾性研究(2006-2019 年)。结果系统性红斑狼疮患者的平均妊娠年龄为(35 ± 7.0)岁,而 UCTD 患者的平均妊娠年龄为(35 ± 6.8)岁(P = 0.349)。系统性红斑狼疮患者中白种女性的比例为 47%,而 UCTD 患者中白种女性的比例为 80%。两组患者均为计划内怀孕(系统性红斑狼疮患者为 81%,系统性红斑狼疮合并症患者为 77%),患者在受孕时疾病并不活跃(系统性红斑狼疮患者为 96%,系统性红斑狼疮合并症患者为 89%)。86%的系统性红斑狼疮妇女在受孕时使用了羟氯喹,而 UCTD 组中只有 36% 的妇女在受孕时使用了羟氯喹。在妊娠期和/或产褥期,系统性红斑狼疮组和尿毒症组的疾病复发率都很低(14% 对 10%)。我们的研究强调了战略性妊娠计划和在整个妊娠期间保持适当治疗的重要性,以确保对系统性红斑狼疮和 UCTD 患者的疾病进行最佳管理,并尽量减少不良后果。
{"title":"Comparing pregnancy outcomes in patients with Systemic Lupus Erythematosus (SLE) and Undifferentiated Connective Tissue Disease (UCTD): a descriptive cohort study","authors":"Candido Muñoz Muñoz ,&nbsp;Filipa Farinha ,&nbsp;Thomas McDonnell ,&nbsp;Hajar J'bari ,&nbsp;Hanh Nguyen ,&nbsp;David Isenberg ,&nbsp;Anisur Rahman ,&nbsp;David Williams ,&nbsp;Jaume Alijotas-Reig ,&nbsp;Ian Giles","doi":"10.1016/j.rceng.2024.04.013","DOIUrl":"10.1016/j.rceng.2024.04.013","url":null,"abstract":"<div><h3>Background</h3><p>Females diagnosed with systemic lupus erythematosus (SLE) face an elevated risk of adverse pregnancy outcomes (APOs). However, the evidence regarding whether a similar association exists in patients with undifferentiated connective tissue disease (UCTD) is inconclusive.</p></div><div><h3>Methods</h3><p>We conducted a retrospective review (2006–2019) of pregnancy outcomes among patients with SLE (n = 51) and UCTD (n = 20) within our institution. We examined the occurrence of various APOs, encompassing miscarriage, stillbirth, termination, preterm birth, pre-eclampsia, eclampsia, HELLP syndrome, intrauterine growth restriction, abruption placentae, congenital heart block, or other cardiac abnormalities.</p></div><div><h3>Results</h3><p>The mean age at pregnancy was 35 ± 7.0 years for patients with SLE and 35 ± 6.8 years for those with UCTD (p = 0.349). The proportion of Caucasian women was 47% in SLE and 80% in UCTD. Pregnancies in both groups were planned (81% in SLE and 77% in UCTD), and patients presented with inactive disease at conception (96% in SLE and 89% in UCTD). Hydroxychloroquine at conception was utilized by 86% of women with SLE, in contrast to 36% in the UCTD group. Both, SLE and UCTD cohorts exhibited low rates of disease flares during pregnancy and/or puerperium (14% vs. 10%). The incidence of APOs was 15.6% in SLE patients compared to 5% in those with UCTD (Risk difference 19.5%; 95% confidence interval: −3.9 to 43.1; p = 0.4237).</p></div><div><h3>Conclusion</h3><p>Our study underscores the importance of strategic pregnancy planning and the maintenance of appropriate treatment throughout pregnancy to ensure optimal disease management and minimize adverse outcomes in both SLE and UCTD pregnancies.</p></div>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":"224 6","pages":"Pages 357-365"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140763727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to editor’s letter “Executive summary of the consensus document on the management of perioperative anemia in Spain” 对编辑 "西班牙围手术期贫血管理共识文件执行摘要 "的回复。
Pub Date : 2024-06-01 DOI: 10.1016/j.rceng.2024.05.005
M. Muñoz, on behalf of the panel of the consensus document on the management of perioperative anemia in Spain
{"title":"Reply to editor’s letter “Executive summary of the consensus document on the management of perioperative anemia in Spain”","authors":"M. Muñoz,&nbsp;on behalf of the panel of the consensus document on the management of perioperative anemia in Spain","doi":"10.1016/j.rceng.2024.05.005","DOIUrl":"10.1016/j.rceng.2024.05.005","url":null,"abstract":"","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":"224 6","pages":"Pages 418-419"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141094843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Initial handgrip strength as a predictive factor for amputation risk in diabetic foot patients 初始手握力是糖尿病足患者截肢风险的预测因素。
Pub Date : 2024-06-01 DOI: 10.1016/j.rceng.2024.04.011
E. Imre , E. Imre , S. Ozturk

Background

We aimed to analyze the prognostic significance of handgrip strength as predictor of lower extremity amputation at 1 year follow up in patients with type 2 diabetes.

Methods

We evaluated 526 patients with type 2 diabetes between August 2020, and, June 2022. We collected from the electronic medical records demographic variables, laboratory data and history of amputation. The handgrip strength was assessed using a handheld Smedley digital dynamometer following the NHANES Muscle Strenght/Grip Test Procedure. Low handgrip strength was defined for women as less than 16 kg and for men less than 27 kg. Outcome variable was major or minor lower extremity amputation.

Results

A total of 205 patients with complete data entered the study. Patients mean age was 59 years old, 37% were women and the mean diabetes disease duration was 14 years. Seventy-seven (37%) patients suffered from lower extremity mputations (26 major and 51 minor amputations). After controlling for age, gender, presence of peripheral artery disease, body mass index and white cell counts as confounder variables, patients with low handgrip had an increased risk for amputations (Odds Ratio 2.17; 95% confidence Interval: 1.09–4.32; <0.001).

Conclusion

Low handgrip stregth is an independent prognostic marker for lower limb amputation at one year in patients with diabetes.

背景我们旨在分析手握力作为 2 型糖尿病患者随访 1 年后下肢截肢预测指标的预后意义。我们从电子病历中收集了人口统计学变量、实验室数据和截肢史。我们按照 NHANES 肌肉力量/握力测试程序,使用手持式 Smedley 数字测力计对患者的手握力进行了评估。女性的低握力定义为低于 16 千克,男性的低握力定义为低于 27 千克。结果变量为主要或次要下肢截肢。患者平均年龄为 59 岁,37% 为女性,平均糖尿病病程为 14 年。77例(37%)患者患有下肢截肢(26例大腿截肢,51例小腿截肢)。在控制了年龄、性别、是否患有外周动脉疾病、体重指数和白细胞计数等混杂变量后,低握力患者截肢的风险增加(Odds Ratio 2.17;95% 置信区间:1.09-4.32;<0.001)。
{"title":"Initial handgrip strength as a predictive factor for amputation risk in diabetic foot patients","authors":"E. Imre ,&nbsp;E. Imre ,&nbsp;S. Ozturk","doi":"10.1016/j.rceng.2024.04.011","DOIUrl":"10.1016/j.rceng.2024.04.011","url":null,"abstract":"<div><h3>Background</h3><p>We aimed to analyze the prognostic significance of handgrip strength as predictor of lower extremity amputation at 1 year follow up in patients with type 2 diabetes.</p></div><div><h3>Methods</h3><p>We evaluated 526 patients with type 2 diabetes between August 2020, and, June 2022. We collected from the electronic medical records demographic variables, laboratory data and history of amputation. The handgrip strength was assessed using a handheld Smedley digital dynamometer following the NHANES Muscle Strenght/Grip Test Procedure. Low handgrip strength was defined for women as less than 16 kg and for men less than 27 kg. Outcome variable was major or minor lower extremity amputation.</p></div><div><h3>Results</h3><p>A total of 205 patients with complete data entered the study. Patients mean age was 59 years old, 37% were women and the mean diabetes disease duration was 14 years. Seventy-seven (37%) patients suffered from lower extremity mputations (26 major and 51 minor amputations). After controlling for age, gender, presence of peripheral artery disease, body mass index and white cell counts as confounder variables, patients with low handgrip had an increased risk for amputations (Odds Ratio 2.17; 95% confidence Interval: 1.09–4.32; &lt;0.001).</p></div><div><h3>Conclusion</h3><p>Low handgrip stregth is an independent prognostic marker for lower limb amputation at one year in patients with diabetes.</p></div>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":"224 6","pages":"Pages 346-356"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140796899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse cardiovascular, obstetric and perinatal events during pregnancy and puerperium in patients with heart disease 心脏病患者在孕期和产褥期的不良心血管、产科和围产期事件。
Pub Date : 2024-06-01 DOI: 10.1016/j.rceng.2024.04.016
N.E. Guzmán-Delgado , C.E. Velázquez-Sotelo , M.J. Fernández-Gómez , L.G. González-Barrera , A. Muñiz-García , V.M. Sánchez-Sotelo , P. Carranza-Rosales , A. Hernández-Juárez , J. Morán-Martínez , V. Martínez-Gaytan

Background and objectives

cardiovascular changes during pregnancy carry greater risk in heart disease. We analyze cardiovascular, obstetric and perinatal adverse effects associated with congenital and acquired heart disease during pregnancy and postpartum.

Materials and methods

Cross-sectional and retrospective study, which included the 2017–2023 registry of pregnant or postpartum patients hospitalised with diagnosis of congenital or acquired heart disease. Adverse events (heart failure, stroke, acute pulmonary edema, maternal death, obstetric haemorrhage, prematurity and perinatal death) were compared with the clinical variables and the implemented treatment.

Results

112 patients with a median age of 28 years (range 15−44) were included. Short circuits predominated 28 (25%). Thirty-six patients (32%) were classified in class IV of the modified WHO scale for maternal cardiovascular risk.

Heart failure occurred in 39 (34.8%), acute lung edema 12 (10.7%), stroke 2 (1.8%), maternal death 5 (4.5%), obstetric haemorrhage 4 (3.6%), prematurity 50 (44.5%) and perinatal death 6 (5.4%). Shunts were associated with prematurity (adjusted odds ratio 4; 95% CI: 1.5−10, p = 0.006). Peripartum cardiomyopathy represented higher risk of pulmonary edema (adjusted OR 34; 95% CI: 6−194, p = 0.001) and heart failure (adjusted OR 16; 95% CI: 3−84, p = 0.001). An increased risk of obstetric haemorrhage was observed in patients with prosthetic valves (adjusted OR 30; 95% CI: 1.5−616, p = 0.025) and with the use of acetylsalicylic acid (adjusted OR 14; 95% CI: 1.2–16, p = 0.030). Furthermore, the latter was associated with perinatal death (adjusted OR 9; 95% CI: 1.4−68, p = 0.021).

Conclusions

severe complications were found during pregnancy and postpartum in patients with heart disease, which is why preconception evaluation and close surveillance are vital.

背景和目的:妊娠期心血管的变化会带来更大的心脏病风险。我们分析了与孕期和产后先天性和后天性心脏病相关的心血管、产科和围产期不良影响。材料和方法:横断面和回顾性研究,其中包括 2017-2023 年登记的诊断为先天性或后天性心脏病住院的孕妇或产后患者。将不良事件(心力衰竭、中风、急性肺水肿、产妇死亡、产科出血、早产和围产期死亡)与临床变量和实施的治疗进行比较:共纳入 112 名患者,中位年龄为 28 岁(15-44 岁不等)。短路患者占 28 人(25%)。36名患者(32%)根据修改后的世界卫生组织孕产妇心血管风险分级表被划分为IV级。心力衰竭 39 例(34.8%),急性肺水肿 12 例(10.7%),中风 2 例(1.8%),产妇死亡 5 例(4.5%),产科出血 4 例(3.6%),早产 50 例(44.5%),围产期死亡 6 例(5.4%)。分流与早产有关(调整后的几率比为 4;95% CI:1.5-10,P = 0.006)。围产期心肌病导致肺水肿(调整后 OR 34;95% CI:6-194,p = 0.001)和心力衰竭(调整后 OR 16;95% CI:3-84,p = 0.001)的风险较高。人工瓣膜患者(调整后 OR 30;95% CI:1.5-616,p = 0.025)和使用乙酰水杨酸的患者(调整后 OR 14;95% CI:1.2-16,p = 0.030)发生产科出血的风险增加。此外,后者还与围产期死亡有关(调整后 OR 9;95% CI:1.4-68,p = 0.021)。结论:心脏病患者在孕期和产后会出现严重的并发症,因此孕前评估和密切监测至关重要。
{"title":"Adverse cardiovascular, obstetric and perinatal events during pregnancy and puerperium in patients with heart disease","authors":"N.E. Guzmán-Delgado ,&nbsp;C.E. Velázquez-Sotelo ,&nbsp;M.J. Fernández-Gómez ,&nbsp;L.G. González-Barrera ,&nbsp;A. Muñiz-García ,&nbsp;V.M. Sánchez-Sotelo ,&nbsp;P. Carranza-Rosales ,&nbsp;A. Hernández-Juárez ,&nbsp;J. Morán-Martínez ,&nbsp;V. Martínez-Gaytan","doi":"10.1016/j.rceng.2024.04.016","DOIUrl":"10.1016/j.rceng.2024.04.016","url":null,"abstract":"<div><h3>Background and objectives</h3><p>cardiovascular changes during pregnancy carry greater risk in heart disease. We analyze cardiovascular, obstetric and perinatal adverse effects associated with congenital and acquired heart disease during pregnancy and postpartum.</p></div><div><h3>Materials and methods</h3><p>Cross-sectional and retrospective study, which included the 2017–2023 registry of pregnant or postpartum patients hospitalised with diagnosis of congenital or acquired heart disease. Adverse events (heart failure, stroke, acute pulmonary edema, maternal death, obstetric haemorrhage, prematurity and perinatal death) were compared with the clinical variables and the implemented treatment.</p></div><div><h3>Results</h3><p>112 patients with a median age of 28 years (range 15−44) were included. Short circuits predominated 28 (25%). Thirty-six patients (32%) were classified in class IV of the modified WHO scale for maternal cardiovascular risk.</p><p>Heart failure occurred in 39 (34.8%), acute lung edema 12 (10.7%), stroke 2 (1.8%), maternal death 5 (4.5%), obstetric haemorrhage 4 (3.6%), prematurity 50 (44.5%) and perinatal death 6 (5.4%). Shunts were associated with prematurity (adjusted odds ratio 4; 95% CI: 1.5−10, <em>p</em> = 0.006). Peripartum cardiomyopathy represented higher risk of pulmonary edema (adjusted OR 34; 95% CI: 6−194, <em>p</em> = 0.001) and heart failure (adjusted OR 16; 95% CI: 3−84, <em>p</em> = 0.001). An increased risk of obstetric haemorrhage was observed in patients with prosthetic valves (adjusted OR 30; 95% CI: 1.5−616, <em>p</em> = 0.025) and with the use of acetylsalicylic acid (adjusted OR 14; 95% CI: 1.2–16, <em>p</em> = 0.030). Furthermore, the latter was associated with perinatal death (adjusted OR 9; 95% CI: 1.4−68, <em>p</em> = 0.021).</p></div><div><h3>Conclusions</h3><p>severe complications were found during pregnancy and postpartum in patients with heart disease, which is why preconception evaluation and close surveillance are vital.</p></div>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":"224 6","pages":"Pages 337-345"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2254887424000675/pdfft?md5=ccf4605611c0705ed39d127cf8db01a3&pid=1-s2.0-S2254887424000675-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140860647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor about the article "How to detect non-institutionalized older patients at risk of malnutrition during their hospitalization? Comparison of 8 screening tools for malnutrition or nutritional risk". 致编辑的信,内容涉及文章 "如何检测住院期间有营养不良风险的非住院老年患者?8种营养不良或营养风险筛查工具的比较"。
Pub Date : 2024-06-01 Epub Date: 2024-05-17 DOI: 10.1016/j.rceng.2024.05.001
F J Teigell Muñoz
{"title":"Letter to the editor about the article \"How to detect non-institutionalized older patients at risk of malnutrition during their hospitalization? Comparison of 8 screening tools for malnutrition or nutritional risk\".","authors":"F J Teigell Muñoz","doi":"10.1016/j.rceng.2024.05.001","DOIUrl":"10.1016/j.rceng.2024.05.001","url":null,"abstract":"","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":" ","pages":"417"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140961430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista clinica espanola
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1